E. M. Link

428 total citations
19 papers, 336 citations indexed

About

E. M. Link is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, E. M. Link has authored 19 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in E. M. Link's work include Radiopharmaceutical Chemistry and Applications (8 papers), bioluminescence and chemiluminescence research (6 papers) and Medical Imaging Techniques and Applications (5 papers). E. M. Link is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (8 papers), bioluminescence and chemiluminescence research (6 papers) and Medical Imaging Techniques and Applications (5 papers). E. M. Link collaborates with scholars based in United Kingdom, Poland and Germany. E. M. Link's co-authors include Patrick A. Riley, I. Brown, Joseph S. B. Mitchell, Stanisław Łukiewicz, A. S. Michalowski, Philip J. Blower, Frank Rösch, Gwenn M. Hansen, D. Lui and Peter J. Ell and has published in prestigious journals such as The Lancet, Biochemical Journal and Journal of Investigative Dermatology.

In The Last Decade

E. M. Link

19 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. M. Link United Kingdom	10	125	113	98	63	49	19	336
Marianne Kelley United States	10	58 0.5×	121 1.1×	72 0.7×	64 1.0×	91 1.9×	17	380
Motofumi Suzuki Japan	10	48 0.4×	207 1.8×	58 0.6×	87 1.4×	45 0.9×	31	360
Haibin Tian United States	11	103 0.8×	95 0.8×	48 0.5×	33 0.5×	33 0.7×	25	350
Robert L. Howell United States	12	47 0.4×	222 2.0×	96 1.0×	36 0.6×	44 0.9×	14	424
Murugesan Subbarayan United States	11	345 2.8×	219 1.9×	135 1.4×	127 2.0×	77 1.6×	12	633
Jeroen Verhoeven Belgium	12	116 0.9×	138 1.2×	63 0.6×	67 1.1×	19 0.4×	30	317
Petra Ohneseit Germany	10	41 0.3×	258 2.3×	126 1.3×	73 1.2×	15 0.3×	14	460
Valeri N. Verovski Belgium	13	48 0.4×	182 1.6×	91 0.9×	54 0.9×	116 2.4×	18	480
Rueyming Loor United States	8	28 0.2×	177 1.6×	135 1.4×	67 1.1×	17 0.3×	9	367
Zijie Mei China	10	41 0.3×	216 1.9×	65 0.7×	54 0.9×	31 0.6×	27	355

Countries citing papers authored by E. M. Link

Since Specialization

Citations

This map shows the geographic impact of E. M. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. Link more than expected).

Fields of papers citing papers by E. M. Link

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. M. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. Link. The network helps show where E. M. Link may publish in the future.

Co-authorship network of co-authors of E. M. Link

This figure shows the co-authorship network connecting the top 25 collaborators of E. M. Link. A scholar is included among the top collaborators of E. M. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. M. Link. E. M. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Giersing, Birgitte, Michael T. Rae, Ranjababu Kulasegaram, et al.. (2000). P38. Matrix metalloproteinases, a target for tumour imaging: In vivo evaluation of radiolabelled N-TIMP2. Nuclear Medicine Communications. 21(4). 406–406. 1 indexed citations

Link, E. M.. (1999). Targeting Melanoma with ²¹¹ At/ ¹³¹ I-Methylene Blue: Preclinical and Clinical Experience. Hybridoma. 18(1). 77–82. 30 indexed citations

Link, E. M., Kevin C. Flanagan, A. S. Michalowski, & Philip J. Blower. (1999). Low-doses of ionising radiation induce melanoma metastases and trigger the immune system—adrenal axis feedback loop. European Journal of Cancer. 35(10). 1526–1533. 4 indexed citations

Link, E. M., Philip J. Blower, Durval C. Costa, et al.. (1998). Early detection of melanoma metastases with radioiodinated methylene blue. European Journal of Nuclear Medicine and Molecular Imaging. 25(9). 1322–1329. 24 indexed citations

Reinhardt, Sigrid, Martin Rentrop, Michael Bachmann, et al.. (1997). De novo acquisition of neuronal polarity in retinoic acid-induced embryonal carcinoma cells.. PubMed. 74(3). 230–45. 21 indexed citations

Blower, Philip J., K.A. Clark, & E. M. Link. (1996). 41. Chemical and biological characterization of components of radioiodinated methylene blue, a melanoma targeting agent. Nuclear Medicine Communications. 17(4). 268–268. 3 indexed citations

Link, E. M., et al.. (1996). Targeting disseminated melanoma with radiolabelled methylene blue. 35(3). 3 indexed citations

Link, E. M., A. S. Michalowski, & Frank Rösch. (1996). 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage. European Journal of Cancer. 32(11). 1986–1994. 14 indexed citations

Link, E. M., et al.. (1996). [211At]Methylene blue for targeted radiotherapy of human melanoma xenografts: Dose fractionation in the treatment of cutaneous tumours. European Journal of Cancer. 32(7). 1240–1247. 15 indexed citations

10.

Ledermann, JA, et al.. (1992). Malignant melanoma. The Lancet. 340(8825). 948–951. 8 indexed citations

11.

Link, E. M., et al.. (1992). 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases.. PubMed. 52(16). 4385–90. 41 indexed citations

12.

Link, E. M., et al.. (1990). 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases.. PubMed. 50(10). 2963–7. 25 indexed citations

13.

Link, E. M., et al.. (1989). Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.. PubMed. 49(15). 4332–7. 38 indexed citations

14.

Link, E. M. & Patrick A. Riley. (1988). Role of hydrogen peroxide in the cytotoxicity of the xanthine/xanthine oxidase system. Biochemical Journal. 249(2). 391–399. 74 indexed citations

15.

Link, E. M., et al.. (1986). High let radioanalogues of methylene blue as potential anti-melanoma agents. Journal of Investigative Dermatology. 87(3). 431. 1 indexed citations

16.

Brown, I., et al.. (1986). Potential diagnostic and therapeutic agents for malignant melanoma: Synthesis of heavy radiohalogenated derivatives of methylene blue by electrophilic and nucleophilic methods. Journal of Radioanalytical and Nuclear Chemistry. 107(6). 337–351. 8 indexed citations

17.

Link, E. M. & Stanisław Łukiewicz. (1982). A new radioactive drug selectively accumulating in melanoma cells. European Journal of Nuclear Medicine and Molecular Imaging. 7(10). 469–473. 19 indexed citations

18.

Łukiewicz, Stanisław, et al.. (1979). Clinical Trials on Chemical Radiosensitization of Malignant Melanoma of the Choroid. Ophthalmologica. 178(4). 194–197. 6 indexed citations

19.

Link, E. M., et al.. (1975). Immunological studies with aortic and venous tissue antigens. I. The antigen structure of vascular tissues.. PubMed. 3(2). 81–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact